Skip to main content
. 2020 Oct 8;20(6):338. doi: 10.3892/ol.2020.12198

Figure 4.

Figure 4.

Kaplan-Meier analyses. (A) DFS according to distinct cutoff values in cancer gland cells. (a) hsa-miR-188-5p. (b) hsa-miR-214-3p. (c) hsa-miR-505-5p. (d) hsa-miR-4455. (e) hsa-miR-6753-3p. (f) hsa-miR-6877-3p. (B) DFS according to distinct cutoff values in cancer stromal cells. (g) hsa-miR-101-5p. (h) hsa-miR-320c. (i) hsa-miR-320d. (j) hsa-miR-320e. (k) hsa-miR-378f. (l) hsa-miR-455-3p. (m) hsa-miR-4429. *P<0.05, **P<0.01. DFS, disease-free survival; miR, microRNA.